1 active trials 0 recruiting 3 disease areas
| Phase 4 | 1 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 4 | ||||
| NCT06762223 | Henagliflozin on Liver Fibrosis in Patients with MASLD and T2DM | Metabolic Dysfunction-associated Steatotic Liver Disease | Not Yet Recruiting | 2025-01-07 |
Diabetes (1) · NASH / MASH (1) · Type 2 Diabetes (1)